Results
41
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
41 companies
Acrux
Market Cap: AU$5.7m
Develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.014
7D
0%
1Y
-75.0%
Genetic Technologies
Market Cap: AU$5.7m
A molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
GTG
AU$0.039
7D
0%
1Y
-68.8%
Biotron
Market Cap: AU$4.6m
A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
BIT
AU$0.003
7D
-14.3%
1Y
-84.2%
Bod Science
Market Cap: AU$4.3m
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States.
BOD
AU$0.024
7D
0%
1Y
-65.2%
BPH Global
Market Cap: AU$2.1m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
0%
1Y
0%